Gut Bacteria May Hold the Key to Treating Bladder Disorders

New research has uncovered a surprising link between gut bacteria and bladder function. Scientists found that a specific bacterium, Akkermansia muciniphila, influences bladder sensitivity through neural pathways. The discovery suggests possible future treatments for conditions like overactive bladder and interstitial cystitis. The study identified a distinct group of sensory neurons called dichotomizing gut-bladder neurons. These neurons create a two-way communication channel between the gut and bladder. When Akkermansia muciniphila colonises the gut, it breaks down mucin, triggering the release of serotonin.

Serotonin then acts on the 5-HT3a receptor (5-HT3aR), increasing the excitability of these neurons. This heightened activity leads to stronger bladder reflexes and greater sensitivity. Blocking the 5-HT3aR receptor with drugs reverses these effects, pointing to its potential as a therapeutic target.

Akkermansia muciniphila was already known for its role in metabolic health, including improved glucose control and reduced inflammation. Now, researchers believe its influence on viscero-visceral crosstalk could extend to other organ systems as well. The findings highlight a novel connection between gut microbes and bladder function. By targeting serotonin signalling or microbiome composition, scientists may develop new treatments for bladder disorders. Further research could explore similar pathways in other organ interactions.